Philip Breitfeld's most recent trade in Champions Oncology Inc was a trade of 13,790 Option to purchase Common Stock done . Disclosure was reported to the exchange on Nov. 5, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Champions Oncology Inc | Philip Breitfeld | Director | 05 Nov 2025 | 13,790 | 13,790 | - | - | Option to purchase Common Stock | ||
| Champions Oncology Inc | Philip Breitfeld | Director | 25 Mar 2025 | 4,150 | 5,717 (0%) | 0% | 0 | Common Stock | ||
| Champions Oncology Inc | Philip Breitfeld | Director | 12 Nov 2024 | 18,715 | 18,715 | - | - | Option to purchase Common Stock | ||
| Champions Oncology Inc | Philip Breitfeld | Director | 03 Nov 2023 | 15,495 | 15,495 | - | - | Option to purchase Common Stock | ||
| Champions Oncology Inc | Philip Breitfeld | Director | 01 Nov 2022 | 11,480 | 11,480 | - | - | Option to purchase Common Stock | ||
| Champions Oncology Inc | Philip Breitfeld | Director | 12 Oct 2022 | 8,333 | 0 | - | - | Option to purchase Common Stock | ||
| Champions Oncology Inc | Philip Breitfeld | Director | 12 Oct 2022 | 8,333 | 18,200 (0%) | 0% | 3.2 | 26,749 | Common Stock | |
| Champions Oncology Inc | Philip Breitfeld | Director | 12 Oct 2022 | 3,562 | 14,638 (0%) | 0% | 7.5 | 26,751 | Common Stock | |
| Champions Oncology Inc | Philip Breitfeld | Director | 05 Nov 2021 | 8,045 | 8,045 | - | - | Option to purchase Common Stock |